NewsBenzingaBristol-Myers Squibb: l’EPS rettificato del terzo trimestre a 1,35 dollari supera la stima di 1,17 dollari; ricavi a 13,069 miliardi di dollari contro stima di 12,738 miliardi di dollari Bristol-Myers Squibb: l’EPS rettificato del terzo trimestre a 1,35 dollari supera la stima di 1,17 dollari; ricavi a 13,069 miliardi di dollari contro stima di 12,738 miliardi di dollari Benzinga 2026.10.29 10:59 (GMT+0) Open on Benzinga Other news Peter Schiff Says AI Stocks Aren’t the ‘Only Bubble’ Out There: The Economist Predicts All Will ‘Deflate,’ but Prediction Market Isn’t Buying It Taiwan Semiconductor (TSM) Stock Trending After Nvidia Posts Strong Q3 Results: What You Should Know Binance Spot and Convert Add 7 bStocks Trading Pairs ‘Not the Nvidia I Know’: Jim Cramer Questions Employee Morale; Colette Kress Has ‘High Confidence’ Staff Still ‘Enjoy’ Their Work Abraxas Capital Moves $109 Million USDC to Binance After Closing Its ~$200 Million Hyperliquid Positions Verisk Analytics, Inc. (VRSK) Presents at J.P. Morgan Ultimate Services Investor Conference 2026 Transcript
Peter Schiff Says AI Stocks Aren’t the ‘Only Bubble’ Out There: The Economist Predicts All Will ‘Deflate,’ but Prediction Market Isn’t Buying It
‘Not the Nvidia I Know’: Jim Cramer Questions Employee Morale; Colette Kress Has ‘High Confidence’ Staff Still ‘Enjoy’ Their Work
Abraxas Capital Moves $109 Million USDC to Binance After Closing Its ~$200 Million Hyperliquid Positions
Verisk Analytics, Inc. (VRSK) Presents at J.P. Morgan Ultimate Services Investor Conference 2026 Transcript